Unexplained biliary pancreatic duct lesion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-100 years; 2. Suspected biliary pancreatic duct lesions; 3. Patients who plan to undergo endoscopic retrograde cholangiopancreatography and choledochoscopy and are willing to undergo confocal microendoscopy; 4. Willing to follow the research procedures; 5. Be willing to sign written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients contraindicated by ERCP surgery; 2. Patients with known allergic diseases, renal failure or asthma as contraindications for fluorescein injection; 3. Allergic to fluorescein dye; 4. Pregnant or lactating patients; 5. Patients deemed unsuitable for study participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ERCP combined with biliary subscope and pCLE in the diagnosis of unexplained biliary pancreatic duct lesions compared the accuracy of histological and pathological results; | — |
Secondary
| Measure | Time frame |
|---|---|
| Area under curve, AUC;Sensitivity, SEN;Specificity, SPE;Positive predictive value, PPV;Negative predictive value, NPV;Incidence rate of adverse events and serious adverse events; | — |
Countries
China
Contacts
The First Affiliated Hospital of Dalian Medical University